Back
Brookline Bancorp Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
33
BRKL
Brookline Bancorp
Last Price:
9.97
Seasonality Move:
1.93%
Sell
18
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
21.00
Seasonality Move:
-9.84%
Sell
33
Brookline Bancorp (BRKL)
is a Sell
Is Brookline Bancorp a Buy, Sell or Hold?
- The current Brookline Bancorp [BRKL] share price is $10.07. The Score for BRKL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BRKL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $21.51. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BRKL Stock Price Chart
What is Brookline Bancorp's stock price today?
-
The Brookline Bancorp share price today is $10.07
The current trend is moderately bearish and BRKL is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $21.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight selling pressure.
BRKL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 51.6 | Buy |
Chaikin Money Flow: | 181167 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.89 - 10.25) | Sell |
Bollinger Bands (100): | (8.58 - 10.1) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.8 | Sell |
Relative Strength Index (14 RSI): | 26.98 | Sell |
Chaikin Money Flow: | -481436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.56 - 62.22) | Sell |
Bollinger Bands (100): | (40.36 - 58.28) | Sell |
BRKL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.21 | Sell |
20-day SMA: | 10.06 | Buy |
50-day SMA: | 10 | Buy |
200-day SMA: | 9.65 | Buy |
8-day EMA: | 10.13 | Sell |
20-day EMA: | 10.07 | Buy |
50-day EMA: | 9.86 | Buy |
200-day EMA: | 9.63 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.47 | Sell |
20-day SMA: | 45.29 | Sell |
50-day SMA: | 51.84 | Sell |
200-day SMA: | 37.33 | Sell |
8-day EMA: | 29.4 | Sell |
20-day EMA: | 40.5 | Sell |
50-day EMA: | 47.43 | Sell |
200-day EMA: | 38.91 | Sell |
Brookline Bancorp Earnings Growth & BRKL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.21 per share, and an increase next year of $0.20 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.64 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
Brookline Bancorp Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |